A novel automated chemiluminescent enzyme immunoassay (CLEIA) for ADAMTS13 activity enables accompanying measurements of the inhibitory autoantibodies

Thrombotic thrombocytopenic purpura (TTP) is a fatal disease caused by severe deficiency in ADAMTS13 activity. ADAMTS13 activity measurement is essential for the diagnosis of TTP, but conventional standard assays are manual and time-consuming. Automated ADAMTS13 activity assays have recently become...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of thrombosis and haemostasis 2024-12
Hauptverfasser:	Kubo, Masayuki, Konko, Kazuyasu, Kinoshita, Emi, Uemae, Satoshi, Kobayashi, Katsushi, Hayashi, Yoshinori, Kan, Akihiko, Fujimura, Yoshihiro, Matsumoto, Masanori
Format:	Artikel
Sprache:	eng
Schlagworte:	ADAMTS13 protein autoantibodies chemiluminescent assays inhibitors thrombotic thrombocytopenic purpura
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!